ACONW
Aclarion IncKey Statistics
About Aclarion Inc
Aclarion Inc is an innovative healthcare technology company dedicated to transforming the diagnosis and treatment of musculoskeletal disorders with its state-of-the-art non-invasive imaging solutions. By harnessing advanced data analytics and proprietary algorithms, Aclarion integrates imaging with clinical data to deliver actionable insights that enhance personalized medicine. This strategic approach not only improves patient outcomes but also optimizes clinical workflows, positioning Aclarion as a leader in healthcare diagnostics. As the company continues to expand its market presence, it remains committed to addressing the evolving needs of both patients and healthcare providers, offering efficient and transformative solutions in the medical landscape.
Fundamentals
| Revenue (TTM) | 75,730 |
| Gross Profit (TTM) | 6,830 |
| EBITDA | $-6.82M |
| Operating Margin | -10785.00% |
| Return on Equity | -104.80% |
| Return on Assets | -55.80% |
| Revenue/Share (TTM) | $0.14 |
| Book Value | $15.02 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 80.60% |
| Shares Outstanding | 0 |
| Float | $2.04M |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Historical Volatility
Volatility is currently contracting